HomeCompareYYYH vs MRK

YYYH vs MRK: Dividend Comparison 2026

YYYH yields 222222.22% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YYYH wins by $1.4076447531278624e+30M in total portfolio value
10 years
YYYH
YYYH
● Live price
222222.22%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4076447531278624e+30M
Annual income
$1,406,399,782,569,334,400,000,000,000,000,000,000.00
Full YYYH calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — YYYH vs MRK

📍 YYYH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodYYYHMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, YYYH + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
YYYH pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

YYYH
Annual income on $10K today (after 15% tax)
$18,888,888.89/yr
After 10yr DRIP, annual income (after tax)
$1,195,439,815,183,934,200,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, YYYH beats the other by $1,195,439,815,183,934,200,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of YYYH + MRK for your $10,000?

YYYH: 50%MRK: 50%
100% MRK50/50100% YYYH
Portfolio after 10yr
$7.038223765639312e+29M
Annual income
$703,199,891,284,667,200,000,000,000,000,000,000.00/yr
Blended yield
99.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

YYYH
No analyst data
Altman Z
-68.1
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

YYYH buys
0
MRK buys
0
No recent congressional trades found for YYYH or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricYYYHMRK
Forward yield222222.22%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1.4076447531278624e+30M$56.8K
Annual income after 10y$1,406,399,782,569,334,400,000,000,000,000,000,000.00$9,798.13
Total dividends collected$1.4075632434891558e+30M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: YYYH vs MRK ($10,000, DRIP)

YearYYYH PortfolioYYYH Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$22,232,922$22,222,222.22$11,206$366.19+$22.22MYYYH
2$46,198,082,523$46,174,293,296.41$12,650$502.35+$46198.07MYYYH
3$89,718,752,943,223$89,669,320,994,923.30$14,407$694.19+$89718752.93MYYYH
4$162,845,393,609,755,680$162,749,394,544,106,430.00$16,585$967.82+$162845393609.74MYYYH
5$276,249,735,879,778,500,000$276,075,491,308,616,120,000.00$19,342$1,363.89+$276249735879778.47MYYYH
6$437,989,462,258,048,500,000,000$437,693,875,040,657,100,000,000.00$22,913$1,947.19+$437989462258048512.00MYYYH
7$649,026,142,700,674,900,000,000,000$648,557,493,976,058,700,000,000,000.00$27,662$2,823.89+$649026142700674875392.00MYYYH
8$898,874,153,179,794,200,000,000,000,000$898,179,695,207,104,400,000,000,000,000.00$34,159$4,173.35+$8.988741531797941e+23MYYYH
9$1,163,523,886,474,633,300,000,000,000,000,000$1,162,562,091,130,731,000,000,000,000,000,000.00$43,337$6,308.80+$1.1635238864746333e+27MYYYH
10$1,407,644,753,127,862,300,000,000,000,000,000,000$1,406,399,782,569,334,400,000,000,000,000,000,000.00$56,776$9,798.13+$1.4076447531278624e+30MYYYH

YYYH vs MRK: Complete Analysis 2026

YYYHStock

China Yanyuan Yuhui Natl Ed Group Inc., a digital advertising technology company, develops and provides advertising software and service solutions in the United States. It operates an advertising technology platform, the MediaShift Monetization Platform, which deploys digital advertisements on WiFi networks at sign-in and while surfing the Internet through display ads and interstitial videos. Its target market comprises network providers offering Internet access to individual and business viewers; and Internet service providers, multiple system operators, and higher education venues with a fixed end-user base to airports, convention centers, hotels, coffee shops, and other venues. The company also operates EducationShift, which focuses on developments in journalism education and MetricShift, which provides content on metrics and analytics and measures impact through original reporting, aggregation, and audience engagement and community. The company sells its products and services directly, as well as through resellers. The company was formerly known as MediaShift, Inc. China Yanyuan Yuhui Natl Ed Group Inc. was founded in 2006 and is based in Oceanside, New York.

Full YYYH Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this YYYH vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

YYYH vs SCHDYYYH vs JEPIYYYH vs OYYYH vs KOYYYH vs MAINYYYH vs JNJYYYH vs ABBVYYYH vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.